Bioavailability study of ORMD-0901in type 2 diabetes mellitus patients
Latest Information Update: 18 Jan 2022
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Oramed Pharmaceuticals
- 12 Jan 2022 According to an Oramed media release, company anticipates initiating this trial in H1 2022.
- 02 Feb 2021 New trial record
- 27 Jan 2021 According to an Oramed media release, company anticipates initiating this trial in 2021.